Medtronic MDT Q2 Projections: Wall Street Analysts Provide Insights into Key Metrics

Medtronic plc (NYSE:MDT), a leading medical technology company, is set to release its second-quarter earnings report. Wall Street analysts have provided insights into the key metrics they are watching for in the report.

Analysts are particularly interested in Medtronic's revenue growth, which is expected to be driven by its cardiac and vascular business segments. The company has been investing heavily in new product development and expanding its market presence, which could lead to strong sales growth.

Another key metric to watch is Medtronic's operating margin. The company has been implementing cost-saving initiatives and improving operational efficiencies, which could contribute to margin expansion.

Additionally, analysts will be paying attention to Medtronic's free cash flow generation. The company has a history of strong cash flow, which enables it to invest in research and development, as well as pursue strategic acquisitions.

Overall, Wall Street analysts are optimistic about Medtronic's performance in the second quarter. They have an average price target of $95.36 for the company's stock, indicating potential upside.

Investors interested in Medtronic should consult with professionals, like Stocks Prognosis, who can provide expert analysis and forecasts on the movement of the company's stock.